Valuation Novartis AG

Stocks

Market Closed - Swiss Exchange Other stock markets 16:30:04 18/06/2026 BST			5-day change	1st Jan Change
118.04 ^CHF	-2.45%		-2.88%	+7.70%

07:11am	Swiss trade surplus at CHF 6.11 bln in May	RE
06-17	Medpace: At the Heart of the Small-Cap Biopharma Crisis

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	196,458	194,448	207,167	195,514	266,003	279,262	-	-
Change	-	-1.02%	6.54%	-5.62%	36.05%	4.98%	-	-
Enterprise Value (EV) ¹	204,649	203,482	219,178	213,458	289,870	311,522	307,560	301,400
Change	-	-0.57%	7.71%	-2.61%	35.8%	7.47%	-1.27%	-2%
P/E	8.2x	28.3x	14.1x	16.5x	19.2x	21.1x	18.1x	15.7x
PBR	2.9x	3.23x	4.41x	4.52x	5.73x	6.33x	5.87x	5.23x
PEG	-	-0.4x	0x	-1x	0.9x	120.07x	1.1x	1.1x
Capitalization / Revenue	3.81x	3.85x	4.44x	3.78x	4.69x	4.9x	4.62x	4.35x
EV / Revenue	3.96x	4.03x	4.7x	4.13x	5.11x	5.46x	5.09x	4.7x
EV / EBITDA	11.2x	10.9x	12.2x	10.2x	12.4x	13.3x	12.1x	10.9x
EV / EBIT	12.3x	12.2x	13.4x	10.9x	13.2x	14.5x	13.2x	11.9x
EV / FCF	15.4x	17x	16.6x	13.1x	16.5x	23x	18.9x	16.2x
FCF Yield	6.49%	5.87%	6.01%	7.61%	6.07%	4.34%	5.28%	6.19%
Dividend per Share ²	3.36	3.5	3.823	3.856	-	4.476	4.601	4.77
Rate of return	3.83%	3.87%	3.79%	3.94%	-	2.93%	3.02%	3.13%
EPS ²	10.71	3.19	7.15	5.92	7.21	7.223	8.434	9.689
Distribution rate	31.4%	110%	53.5%	65.1%	-	62%	54.6%	49.2%
Net sales ¹	51,626	50,545	46,660	51,722	56,674	57,018	60,425	64,153
EBITDA ¹	18,246	18,613	17,937	21,006	23,415	23,510	25,343	27,542
EBIT ¹	16,588	16,665	16,372	19,494	21,889	21,525	23,297	25,275
Net income ¹	24,021	6,955	14,854	11,939	13,967	14,148	15,672	17,555
Net Debt ¹	8,191	9,034	12,011	17,944	23,867	32,260	28,298	22,138
Reference price ²	87.82	90.40	100.79	97.79	138.63	152.56	152.56	152.56
Nbr of stocks (in thousands)	2,237,092	2,150,980	2,055,460	1,999,270	1,918,792	1,830,549	-	-
Announcement Date	02/02/22	01/02/23	31/01/24	31/01/25	04/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
NOVARTIS AG	21.12x	5.46x	13.25x	2.94%	279B
ELI LILLY AND COMPANY	32.54x	11.83x	24.36x	0.61%	992B
JOHNSON & JOHNSON	25.03x	5.77x	15.69x	2.28%	564B
ABBVIE INC.	27.45x	6.62x	13.53x	3.1%	391B
ROCHE HOLDING AG	17.47x	4.34x	10.68x	3.06%	330B
ASTRAZENECA PLC	22.62x	4.72x	13.39x	1.85%	280B
NOVO NORDISK A/S	12.67x	4.72x	9.72x	3.98%	196B
AMGEN INC.	22.21x	5.97x	10.43x	2.95%	184B
GILEAD SCIENCES, INC.	-44.95x	5.42x	29.92x	2.59%	156B
PFIZER INC.	12.12x	3.18x	7.73x	6.76%	148B
Average	14.83x	5.80x	14.87x	3.01%	351.9B
Weighted average by Cap.	21.73x	7.16x	16.74x	2.32%